AB Science S.A.
AB Science S.A. (ABSCF) Stock Competitors & Peer Comparison
See (ABSCF) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ABSCF | $1.45 | +0.00% | 96M | -8.53 | -$0.17 | N/A |
| IPSEY | $44.63 | +0.00% | 59B | 29.17 | $1.53 | +0.89% |
| TKPHF | $33.70 | +0.00% | 57B | 81.94 | $0.44 | +3.67% |
| MKGAF | $127.60 | +0.00% | 54.4B | 16.01 | $7.82 | +2.00% |
| MKKGY | $24.89 | +0.00% | 51.9B | 15.29 | $1.56 | +2.10% |
| HLNCF | $5.12 | +0.00% | 43.2B | 19.40 | $0.25 | +1.89% |
| SDZNY | $78.02 | +0.00% | 33.2B | 36.71 | $2.09 | +0.95% |
| TEVJF | $28.36 | +0.00% | 32.5B | 23.44 | $1.21 | N/A |
| SGIOF | $23.63 | +0.00% | 20.1B | 18.46 | $1.28 | +1.87% |
| TAIPY | $14.00 | +16.67% | 18.1B | 82.35 | $0.17 | N/A |
Stock Comparison
ABSCF vs IPSEY Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, IPSEY has a market cap of 59B. Regarding current trading prices, ABSCF is priced at $1.45, while IPSEY trades at $44.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas IPSEY's P/E ratio is 29.17. In terms of profitability, ABSCF's ROE is +0.33%, compared to IPSEY's ROE of +0.10%. Regarding short-term risk, ABSCF and IPSEY have similar daily volatility (0.00).Check IPSEY's competition here
ABSCF vs TKPHF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, TKPHF has a market cap of 57B. Regarding current trading prices, ABSCF is priced at $1.45, while TKPHF trades at $33.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas TKPHF's P/E ratio is 81.94. In terms of profitability, ABSCF's ROE is +0.33%, compared to TKPHF's ROE of +0.02%. Regarding short-term risk, ABSCF and TKPHF have similar daily volatility (0.00).Check TKPHF's competition here
ABSCF vs MKGAF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, MKGAF has a market cap of 54.4B. Regarding current trading prices, ABSCF is priced at $1.45, while MKGAF trades at $127.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas MKGAF's P/E ratio is 16.01. In terms of profitability, ABSCF's ROE is +0.33%, compared to MKGAF's ROE of +0.09%. Regarding short-term risk, ABSCF is less volatile compared to MKGAF. This indicates potentially lower risk in terms of short-term price fluctuations for ABSCF.Check MKGAF's competition here
ABSCF vs MKKGY Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, MKKGY has a market cap of 51.9B. Regarding current trading prices, ABSCF is priced at $1.45, while MKKGY trades at $24.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas MKKGY's P/E ratio is 15.29. In terms of profitability, ABSCF's ROE is +0.33%, compared to MKKGY's ROE of +0.09%. Regarding short-term risk, ABSCF is less volatile compared to MKKGY. This indicates potentially lower risk in terms of short-term price fluctuations for ABSCF.Check MKKGY's competition here
ABSCF vs HLNCF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, HLNCF has a market cap of 43.2B. Regarding current trading prices, ABSCF is priced at $1.45, while HLNCF trades at $5.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas HLNCF's P/E ratio is 19.40. In terms of profitability, ABSCF's ROE is +0.33%, compared to HLNCF's ROE of +0.09%. Regarding short-term risk, ABSCF is less volatile compared to HLNCF. This indicates potentially lower risk in terms of short-term price fluctuations for ABSCF.Check HLNCF's competition here
ABSCF vs SDZNY Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, SDZNY has a market cap of 33.2B. Regarding current trading prices, ABSCF is priced at $1.45, while SDZNY trades at $78.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas SDZNY's P/E ratio is 36.71. In terms of profitability, ABSCF's ROE is +0.33%, compared to SDZNY's ROE of +0.08%. Regarding short-term risk, ABSCF is less volatile compared to SDZNY. This indicates potentially lower risk in terms of short-term price fluctuations for ABSCF.Check SDZNY's competition here
ABSCF vs TEVJF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, TEVJF has a market cap of 32.5B. Regarding current trading prices, ABSCF is priced at $1.45, while TEVJF trades at $28.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas TEVJF's P/E ratio is 23.44. In terms of profitability, ABSCF's ROE is +0.33%, compared to TEVJF's ROE of +0.20%. Regarding short-term risk, ABSCF and TEVJF have similar daily volatility (0.00).Check TEVJF's competition here
ABSCF vs SGIOF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, SGIOF has a market cap of 20.1B. Regarding current trading prices, ABSCF is priced at $1.45, while SGIOF trades at $23.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas SGIOF's P/E ratio is 18.46. In terms of profitability, ABSCF's ROE is +0.33%, compared to SGIOF's ROE of +0.14%. Regarding short-term risk, ABSCF and SGIOF have similar daily volatility (0.00).Check SGIOF's competition here
ABSCF vs TAIPY Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, TAIPY has a market cap of 18.1B. Regarding current trading prices, ABSCF is priced at $1.45, while TAIPY trades at $14.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas TAIPY's P/E ratio is 82.35. In terms of profitability, ABSCF's ROE is +0.33%, compared to TAIPY's ROE of +0.02%. Regarding short-term risk, ABSCF is less volatile compared to TAIPY. This indicates potentially lower risk in terms of short-term price fluctuations for ABSCF.Check TAIPY's competition here
ABSCF vs ESALY Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, ESALY has a market cap of 17.6B. Regarding current trading prices, ABSCF is priced at $1.45, while ESALY trades at $61.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas ESALY's P/E ratio is 20.54. In terms of profitability, ABSCF's ROE is +0.33%, compared to ESALY's ROE of +0.06%. Regarding short-term risk, ABSCF is less volatile compared to ESALY. This indicates potentially lower risk in terms of short-term price fluctuations for ABSCF.Check ESALY's competition here
ABSCF vs SGIOY Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, SGIOY has a market cap of 17.5B. Regarding current trading prices, ABSCF is priced at $1.45, while SGIOY trades at $10.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas SGIOY's P/E ratio is 16.32. In terms of profitability, ABSCF's ROE is +0.33%, compared to SGIOY's ROE of +0.14%. Regarding short-term risk, ABSCF is less volatile compared to SGIOY. This indicates potentially lower risk in terms of short-term price fluctuations for ABSCF.Check SGIOY's competition here
ABSCF vs BIOVF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, BIOVF has a market cap of 14.3B. Regarding current trading prices, ABSCF is priced at $1.45, while BIOVF trades at $41.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas BIOVF's P/E ratio is 295.14. In terms of profitability, ABSCF's ROE is +0.33%, compared to BIOVF's ROE of +0.01%. Regarding short-term risk, ABSCF and BIOVF have similar daily volatility (0.00).Check BIOVF's competition here
ABSCF vs IPSEF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, IPSEF has a market cap of 9.4B. Regarding current trading prices, ABSCF is priced at $1.45, while IPSEF trades at $113.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas IPSEF's P/E ratio is 18.07. In terms of profitability, ABSCF's ROE is +0.33%, compared to IPSEF's ROE of +0.12%. Regarding short-term risk, ABSCF and IPSEF have similar daily volatility (0.00).Check IPSEF's competition here
ABSCF vs ESALF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, ESALF has a market cap of 8.6B. Regarding current trading prices, ABSCF is priced at $1.45, while ESALF trades at $30.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas ESALF's P/E ratio is 27.82. In terms of profitability, ABSCF's ROE is +0.33%, compared to ESALF's ROE of +0.05%. Regarding short-term risk, ABSCF and ESALF have similar daily volatility (0.00).Check ESALF's competition here
ABSCF vs ESAIY Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, ESAIY has a market cap of 8.3B. Regarding current trading prices, ABSCF is priced at $1.45, while ESAIY trades at $7.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas ESAIY's P/E ratio is 27.07. In terms of profitability, ABSCF's ROE is +0.33%, compared to ESAIY's ROE of +0.05%. Regarding short-term risk, ABSCF is less volatile compared to ESAIY. This indicates potentially lower risk in terms of short-term price fluctuations for ABSCF.Check ESAIY's competition here
ABSCF vs SFOSF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, SFOSF has a market cap of 6.5B. Regarding current trading prices, ABSCF is priced at $1.45, while SFOSF trades at $2.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas SFOSF's P/E ratio is 13.53. In terms of profitability, ABSCF's ROE is +0.33%, compared to SFOSF's ROE of +0.07%. Regarding short-term risk, ABSCF and SFOSF have similar daily volatility (0.00).Check SFOSF's competition here
ABSCF vs LVZPF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, LVZPF has a market cap of 6.1B. Regarding current trading prices, ABSCF is priced at $1.45, while LVZPF trades at $5.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas LVZPF's P/E ratio is 15.35. In terms of profitability, ABSCF's ROE is +0.33%, compared to LVZPF's ROE of +0.15%. Regarding short-term risk, ABSCF and LVZPF have similar daily volatility (0.00).Check LVZPF's competition here
ABSCF vs GZPHF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, GZPHF has a market cap of 5.9B. Regarding current trading prices, ABSCF is priced at $1.45, while GZPHF trades at $2.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas GZPHF's P/E ratio is 9.00. In terms of profitability, ABSCF's ROE is +0.33%, compared to GZPHF's ROE of +0.08%. Regarding short-term risk, ABSCF and GZPHF have similar daily volatility (0.00).Check GZPHF's competition here
ABSCF vs DNPUF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, DNPUF has a market cap of 5.5B. Regarding current trading prices, ABSCF is priced at $1.45, while DNPUF trades at $13.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas DNPUF's P/E ratio is 5.60. In terms of profitability, ABSCF's ROE is +0.33%, compared to DNPUF's ROE of +0.49%. Regarding short-term risk, ABSCF and DNPUF have similar daily volatility (0.00).Check DNPUF's competition here
ABSCF vs HLUBF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, HLUBF has a market cap of 4.8B. Regarding current trading prices, ABSCF is priced at $1.45, while HLUBF trades at $4.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas HLUBF's P/E ratio is 9.64. In terms of profitability, ABSCF's ROE is +0.33%, compared to HLUBF's ROE of +0.13%. Regarding short-term risk, ABSCF and HLUBF have similar daily volatility (0.00).Check HLUBF's competition here
ABSCF vs HLBBF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, HLBBF has a market cap of 4.5B. Regarding current trading prices, ABSCF is priced at $1.45, while HLBBF trades at $5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas HLBBF's P/E ratio is 11.18. In terms of profitability, ABSCF's ROE is +0.33%, compared to HLBBF's ROE of +0.13%. Regarding short-term risk, ABSCF and HLBBF have similar daily volatility (0.00).Check HLBBF's competition here
ABSCF vs SMDPY Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, SMDPY has a market cap of 4.5B. Regarding current trading prices, ABSCF is priced at $1.45, while SMDPY trades at $12.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas SMDPY's P/E ratio is 4.59. In terms of profitability, ABSCF's ROE is +0.33%, compared to SMDPY's ROE of +0.49%. Regarding short-term risk, ABSCF and SMDPY have similar daily volatility (0.00).Check SMDPY's competition here
ABSCF vs SGFEF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, SGFEF has a market cap of 4.4B. Regarding current trading prices, ABSCF is priced at $1.45, while SGFEF trades at $100.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas SGFEF's P/E ratio is 20.45. In terms of profitability, ABSCF's ROE is +0.33%, compared to SGFEF's ROE of +0.16%. Regarding short-term risk, ABSCF and SGFEF have similar daily volatility (0.00).Check SGFEF's competition here
ABSCF vs HKMPF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, HKMPF has a market cap of 3.8B. Regarding current trading prices, ABSCF is priced at $1.45, while HKMPF trades at $17.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas HKMPF's P/E ratio is 9.56. In terms of profitability, ABSCF's ROE is +0.33%, compared to HKMPF's ROE of +0.16%. Regarding short-term risk, ABSCF and HKMPF have similar daily volatility (0.00).Check HKMPF's competition here
ABSCF vs HKMPY Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, HKMPY has a market cap of 3.8B. Regarding current trading prices, ABSCF is priced at $1.45, while HKMPY trades at $34.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas HKMPY's P/E ratio is 9.43. In terms of profitability, ABSCF's ROE is +0.33%, compared to HKMPY's ROE of +0.16%. Regarding short-term risk, ABSCF is less volatile compared to HKMPY. This indicates potentially lower risk in terms of short-term price fluctuations for ABSCF.Check HKMPY's competition here
ABSCF vs APNHF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, APNHF has a market cap of 3.6B. Regarding current trading prices, ABSCF is priced at $1.45, while APNHF trades at $8.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas APNHF's P/E ratio is -34.17. In terms of profitability, ABSCF's ROE is +0.33%, compared to APNHF's ROE of -0.02%. Regarding short-term risk, ABSCF and APNHF have similar daily volatility (0.00).Check APNHF's competition here
ABSCF vs APNHY Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, APNHY has a market cap of 3.5B. Regarding current trading prices, ABSCF is priced at $1.45, while APNHY trades at $7.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas APNHY's P/E ratio is -32.92. In terms of profitability, ABSCF's ROE is +0.33%, compared to APNHY's ROE of -0.02%. Regarding short-term risk, ABSCF and APNHY have similar daily volatility (0.00).Check APNHY's competition here
ABSCF vs ULIHF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, ULIHF has a market cap of 3.4B. Regarding current trading prices, ABSCF is priced at $1.45, while ULIHF trades at $1.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas ULIHF's P/E ratio is 7.08. In terms of profitability, ABSCF's ROE is +0.33%, compared to ULIHF's ROE of +0.20%. Regarding short-term risk, ABSCF and ULIHF have similar daily volatility (0.00).Check ULIHF's competition here
ABSCF vs LBTSF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, LBTSF has a market cap of 3.3B. Regarding current trading prices, ABSCF is priced at $1.45, while LBTSF trades at $15.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas LBTSF's P/E ratio is 61.40. In terms of profitability, ABSCF's ROE is +0.33%, compared to LBTSF's ROE of +0.04%. Regarding short-term risk, ABSCF and LBTSF have similar daily volatility (0.00).Check LBTSF's competition here
ABSCF vs CHSYF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, CHSYF has a market cap of 3.3B. Regarding current trading prices, ABSCF is priced at $1.45, while CHSYF trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas CHSYF's P/E ratio is 13.50. In terms of profitability, ABSCF's ROE is +0.33%, compared to CHSYF's ROE of +0.09%. Regarding short-term risk, ABSCF and CHSYF have similar daily volatility (0.00).Check CHSYF's competition here
ABSCF vs INVVY Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, INVVY has a market cap of 3B. Regarding current trading prices, ABSCF is priced at $1.45, while INVVY trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas INVVY's P/E ratio is -62.42. In terms of profitability, ABSCF's ROE is +0.33%, compared to INVVY's ROE of -0.99%. Regarding short-term risk, ABSCF and INVVY have similar daily volatility (0.00).Check INVVY's competition here
ABSCF vs IZQVF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, IZQVF has a market cap of 2.9B. Regarding current trading prices, ABSCF is priced at $1.45, while IZQVF trades at $20.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas IZQVF's P/E ratio is -56.68. In terms of profitability, ABSCF's ROE is +0.33%, compared to IZQVF's ROE of -0.99%. Regarding short-term risk, ABSCF and IZQVF have similar daily volatility (0.00).Check IZQVF's competition here
ABSCF vs HYPMY Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, HYPMY has a market cap of 2.6B. Regarding current trading prices, ABSCF is priced at $1.45, while HYPMY trades at $4.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas HYPMY's P/E ratio is 11.33. In terms of profitability, ABSCF's ROE is +0.33%, compared to HYPMY's ROE of +0.10%. Regarding short-term risk, ABSCF is less volatile compared to HYPMY. This indicates potentially lower risk in terms of short-term price fluctuations for ABSCF.Check HYPMY's competition here
ABSCF vs HMDCF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, HMDCF has a market cap of 2.4B. Regarding current trading prices, ABSCF is priced at $1.45, while HMDCF trades at $2.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas HMDCF's P/E ratio is 5.32. In terms of profitability, ABSCF's ROE is +0.33%, compared to HMDCF's ROE of +0.42%. Regarding short-term risk, ABSCF and HMDCF have similar daily volatility (0.00).Check HMDCF's competition here
ABSCF vs NPPNY Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, NPPNY has a market cap of 2.3B. Regarding current trading prices, ABSCF is priced at $1.45, while NPPNY trades at $8.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas NPPNY's P/E ratio is 11.42. In terms of profitability, ABSCF's ROE is +0.33%, compared to NPPNY's ROE of +0.12%. Regarding short-term risk, ABSCF and NPPNY have similar daily volatility (0.00).Check NPPNY's competition here
ABSCF vs NPNKF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, NPNKF has a market cap of 2.2B. Regarding current trading prices, ABSCF is priced at $1.45, while NPNKF trades at $32.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas NPNKF's P/E ratio is 10.77. In terms of profitability, ABSCF's ROE is +0.33%, compared to NPNKF's ROE of +0.11%. Regarding short-term risk, ABSCF and NPNKF have similar daily volatility (0.00).Check NPNKF's competition here
ABSCF vs DMPHF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, DMPHF has a market cap of 2.1B. Regarding current trading prices, ABSCF is priced at $1.45, while DMPHF trades at $39.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas DMPHF's P/E ratio is 17.90. In terms of profitability, ABSCF's ROE is +0.33%, compared to DMPHF's ROE of +0.19%. Regarding short-term risk, ABSCF and DMPHF have similar daily volatility (0.00).Check DMPHF's competition here
ABSCF vs HTSUF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, HTSUF has a market cap of 2B. Regarding current trading prices, ABSCF is priced at $1.45, while HTSUF trades at $29.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas HTSUF's P/E ratio is 16.76. In terms of profitability, ABSCF's ROE is +0.33%, compared to HTSUF's ROE of +0.07%. Regarding short-term risk, ABSCF and HTSUF have similar daily volatility (0.00).Check HTSUF's competition here
ABSCF vs ARSUF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, ARSUF has a market cap of 2B. Regarding current trading prices, ABSCF is priced at $1.45, while ARSUF trades at $27.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas ARSUF's P/E ratio is 18.88. In terms of profitability, ABSCF's ROE is +0.33%, compared to ARSUF's ROE of +0.17%. Regarding short-term risk, ABSCF and ARSUF have similar daily volatility (0.00).Check ARSUF's competition here
ABSCF vs DUTV Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, DUTV has a market cap of 1.9B. Regarding current trading prices, ABSCF is priced at $1.45, while DUTV trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas DUTV's P/E ratio is N/A. In terms of profitability, ABSCF's ROE is +0.33%, compared to DUTV's ROE of -0.04%. Regarding short-term risk, ABSCF is less volatile compared to DUTV. This indicates potentially lower risk in terms of short-term price fluctuations for ABSCF.Check DUTV's competition here
ABSCF vs TSMRF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, TSMRF has a market cap of 1.7B. Regarding current trading prices, ABSCF is priced at $1.45, while TSMRF trades at $23.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas TSMRF's P/E ratio is 10.04. In terms of profitability, ABSCF's ROE is +0.33%, compared to TSMRF's ROE of +0.10%. Regarding short-term risk, ABSCF and TSMRF have similar daily volatility (0.00).Check TSMRF's competition here
ABSCF vs SHPHF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, SHPHF has a market cap of 1.7B. Regarding current trading prices, ABSCF is priced at $1.45, while SHPHF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas SHPHF's P/E ratio is -6.22. In terms of profitability, ABSCF's ROE is +0.33%, compared to SHPHF's ROE of -0.02%. Regarding short-term risk, ABSCF and SHPHF have similar daily volatility (0.00).Check SHPHF's competition here
ABSCF vs CURLF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, CURLF has a market cap of 1.7B. Regarding current trading prices, ABSCF is priced at $1.45, while CURLF trades at $2.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas CURLF's P/E ratio is -6.68. In terms of profitability, ABSCF's ROE is +0.33%, compared to CURLF's ROE of -0.29%. Regarding short-term risk, ABSCF is less volatile compared to CURLF. This indicates potentially lower risk in terms of short-term price fluctuations for ABSCF.Check CURLF's competition here
ABSCF vs MITPF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, MITPF has a market cap of 1.6B. Regarding current trading prices, ABSCF is priced at $1.45, while MITPF trades at $23.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas MITPF's P/E ratio is -10.81. In terms of profitability, ABSCF's ROE is +0.33%, compared to MITPF's ROE of +4.99%. Regarding short-term risk, ABSCF is less volatile compared to MITPF. This indicates potentially lower risk in terms of short-term price fluctuations for ABSCF.Check MITPF's competition here
ABSCF vs KARBF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, KARBF has a market cap of 1.5B. Regarding current trading prices, ABSCF is priced at $1.45, while KARBF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas KARBF's P/E ratio is 262.50. In terms of profitability, ABSCF's ROE is +0.33%, compared to KARBF's ROE of N/A. Regarding short-term risk, ABSCF and KARBF have similar daily volatility (0.00).Check KARBF's competition here
ABSCF vs GTBIF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, GTBIF has a market cap of 1.5B. Regarding current trading prices, ABSCF is priced at $1.45, while GTBIF trades at $6.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas GTBIF's P/E ratio is 13.10. In terms of profitability, ABSCF's ROE is +0.33%, compared to GTBIF's ROE of +0.06%. Regarding short-term risk, ABSCF is less volatile compared to GTBIF. This indicates potentially lower risk in terms of short-term price fluctuations for ABSCF.Check GTBIF's competition here
ABSCF vs CHIZF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, CHIZF has a market cap of 1.4B. Regarding current trading prices, ABSCF is priced at $1.45, while CHIZF trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas CHIZF's P/E ratio is -27.34. In terms of profitability, ABSCF's ROE is +0.33%, compared to CHIZF's ROE of -0.01%. Regarding short-term risk, ABSCF and CHIZF have similar daily volatility (0.00).Check CHIZF's competition here
ABSCF vs CASBF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, CASBF has a market cap of 1.3B. Regarding current trading prices, ABSCF is priced at $1.45, while CASBF trades at $3.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas CASBF's P/E ratio is -38.60. In terms of profitability, ABSCF's ROE is +0.33%, compared to CASBF's ROE of +0.01%. Regarding short-term risk, ABSCF and CASBF have similar daily volatility (0.00).Check CASBF's competition here
ABSCF vs SWGHF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, SWGHF has a market cap of 1.3B. Regarding current trading prices, ABSCF is priced at $1.45, while SWGHF trades at $11.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas SWGHF's P/E ratio is 15.57. In terms of profitability, ABSCF's ROE is +0.33%, compared to SWGHF's ROE of +0.05%. Regarding short-term risk, ABSCF and SWGHF have similar daily volatility (0.00).Check SWGHF's competition here
ABSCF vs LJUIF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, LJUIF has a market cap of 1.2B. Regarding current trading prices, ABSCF is priced at $1.45, while LJUIF trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas LJUIF's P/E ratio is 13.42. In terms of profitability, ABSCF's ROE is +0.33%, compared to LJUIF's ROE of +0.09%. Regarding short-term risk, ABSCF and LJUIF have similar daily volatility (0.00).Check LJUIF's competition here
ABSCF vs TCNNF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, TCNNF has a market cap of 1.2B. Regarding current trading prices, ABSCF is priced at $1.45, while TCNNF trades at $6.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas TCNNF's P/E ratio is -10.34. In terms of profitability, ABSCF's ROE is +0.33%, compared to TCNNF's ROE of -0.10%. Regarding short-term risk, ABSCF is less volatile compared to TCNNF. This indicates potentially lower risk in terms of short-term price fluctuations for ABSCF.Check TCNNF's competition here
ABSCF vs BIOGY Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, BIOGY has a market cap of 1.1B. Regarding current trading prices, ABSCF is priced at $1.45, while BIOGY trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas BIOGY's P/E ratio is 31.43. In terms of profitability, ABSCF's ROE is +0.33%, compared to BIOGY's ROE of +0.24%. Regarding short-term risk, ABSCF and BIOGY have similar daily volatility (0.00).Check BIOGY's competition here
ABSCF vs KSPHF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, KSPHF has a market cap of 1.1B. Regarding current trading prices, ABSCF is priced at $1.45, while KSPHF trades at $25.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas KSPHF's P/E ratio is 11.99. In terms of profitability, ABSCF's ROE is +0.33%, compared to KSPHF's ROE of +0.07%. Regarding short-term risk, ABSCF and KSPHF have similar daily volatility (0.00).Check KSPHF's competition here
ABSCF vs KKPCF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, KKPCF has a market cap of 984.6M. Regarding current trading prices, ABSCF is priced at $1.45, while KKPCF trades at $26.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas KKPCF's P/E ratio is 288.89. In terms of profitability, ABSCF's ROE is +0.33%, compared to KKPCF's ROE of -0.03%. Regarding short-term risk, ABSCF and KKPCF have similar daily volatility (0.00).Check KKPCF's competition here
ABSCF vs GNMLF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, GNMLF has a market cap of 973.8M. Regarding current trading prices, ABSCF is priced at $1.45, while GNMLF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas GNMLF's P/E ratio is 11.11. In terms of profitability, ABSCF's ROE is +0.33%, compared to GNMLF's ROE of +0.11%. Regarding short-term risk, ABSCF and GNMLF have similar daily volatility (0.00).Check GNMLF's competition here
ABSCF vs EVOTF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, EVOTF has a market cap of 931.2M. Regarding current trading prices, ABSCF is priced at $1.45, while EVOTF trades at $5.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas EVOTF's P/E ratio is -5.04. In terms of profitability, ABSCF's ROE is +0.33%, compared to EVOTF's ROE of -0.18%. Regarding short-term risk, ABSCF and EVOTF have similar daily volatility (0.00).Check EVOTF's competition here
ABSCF vs TWAPF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, TWAPF has a market cap of 828.5M. Regarding current trading prices, ABSCF is priced at $1.45, while TWAPF trades at $16.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas TWAPF's P/E ratio is 6.28. In terms of profitability, ABSCF's ROE is +0.33%, compared to TWAPF's ROE of +0.12%. Regarding short-term risk, ABSCF and TWAPF have similar daily volatility (0.00).Check TWAPF's competition here
ABSCF vs NIKA Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, NIKA has a market cap of 785.6M. Regarding current trading prices, ABSCF is priced at $1.45, while NIKA trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas NIKA's P/E ratio is N/A. In terms of profitability, ABSCF's ROE is +0.33%, compared to NIKA's ROE of +0.21%. Regarding short-term risk, ABSCF and NIKA have similar daily volatility (0.00).Check NIKA's competition here
ABSCF vs CSWYF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, CSWYF has a market cap of 758.4M. Regarding current trading prices, ABSCF is priced at $1.45, while CSWYF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas CSWYF's P/E ratio is 4.78. In terms of profitability, ABSCF's ROE is +0.33%, compared to CSWYF's ROE of +0.20%. Regarding short-term risk, ABSCF and CSWYF have similar daily volatility (0.00).Check CSWYF's competition here
ABSCF vs TRXPF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, TRXPF has a market cap of 690.7M. Regarding current trading prices, ABSCF is priced at $1.45, while TRXPF trades at $24.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas TRXPF's P/E ratio is 25.86. In terms of profitability, ABSCF's ROE is +0.33%, compared to TRXPF's ROE of +0.04%. Regarding short-term risk, ABSCF and TRXPF have similar daily volatility (0.00).Check TRXPF's competition here
ABSCF vs SHEZF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, SHEZF has a market cap of 690.3M. Regarding current trading prices, ABSCF is priced at $1.45, while SHEZF trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas SHEZF's P/E ratio is -23.48. In terms of profitability, ABSCF's ROE is +0.33%, compared to SHEZF's ROE of +0.03%. Regarding short-term risk, ABSCF and SHEZF have similar daily volatility (0.00).Check SHEZF's competition here
ABSCF vs YIHCF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, YIHCF has a market cap of 643.1M. Regarding current trading prices, ABSCF is priced at $1.45, while YIHCF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas YIHCF's P/E ratio is -5.00. In terms of profitability, ABSCF's ROE is +0.33%, compared to YIHCF's ROE of +0.06%. Regarding short-term risk, ABSCF and YIHCF have similar daily volatility (0.00).Check YIHCF's competition here
ABSCF vs AIHLF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, AIHLF has a market cap of 624.3M. Regarding current trading prices, ABSCF is priced at $1.45, while AIHLF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas AIHLF's P/E ratio is 10.94. In terms of profitability, ABSCF's ROE is +0.33%, compared to AIHLF's ROE of +0.15%. Regarding short-term risk, ABSCF and AIHLF have similar daily volatility (0.00).Check AIHLF's competition here
ABSCF vs TRSSF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, TRSSF has a market cap of 601.9M. Regarding current trading prices, ABSCF is priced at $1.45, while TRSSF trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas TRSSF's P/E ratio is -1.32. In terms of profitability, ABSCF's ROE is +0.33%, compared to TRSSF's ROE of -0.68%. Regarding short-term risk, ABSCF is less volatile compared to TRSSF. This indicates potentially lower risk in terms of short-term price fluctuations for ABSCF.Check TRSSF's competition here
ABSCF vs PKBFF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, PKBFF has a market cap of 544.7M. Regarding current trading prices, ABSCF is priced at $1.45, while PKBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas PKBFF's P/E ratio is N/A. In terms of profitability, ABSCF's ROE is +0.33%, compared to PKBFF's ROE of +7.96%. Regarding short-term risk, ABSCF and PKBFF have similar daily volatility (0.00).Check PKBFF's competition here
ABSCF vs GLASF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, GLASF has a market cap of 538.5M. Regarding current trading prices, ABSCF is priced at $1.45, while GLASF trades at $7.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas GLASF's P/E ratio is -33.18. In terms of profitability, ABSCF's ROE is +0.33%, compared to GLASF's ROE of -0.01%. Regarding short-term risk, ABSCF is less volatile compared to GLASF. This indicates potentially lower risk in terms of short-term price fluctuations for ABSCF.Check GLASF's competition here
ABSCF vs CCHWF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, CCHWF has a market cap of 521.3M. Regarding current trading prices, ABSCF is priced at $1.45, while CCHWF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas CCHWF's P/E ratio is -1.12. In terms of profitability, ABSCF's ROE is +0.33%, compared to CCHWF's ROE of +0.42%. Regarding short-term risk, ABSCF is less volatile compared to CCHWF. This indicates potentially lower risk in terms of short-term price fluctuations for ABSCF.Check CCHWF's competition here
ABSCF vs BOIRF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, BOIRF has a market cap of 520.9M. Regarding current trading prices, ABSCF is priced at $1.45, while BOIRF trades at $30.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas BOIRF's P/E ratio is 22.73. In terms of profitability, ABSCF's ROE is +0.33%, compared to BOIRF's ROE of +0.05%. Regarding short-term risk, ABSCF and BOIRF have similar daily volatility (0.00).Check BOIRF's competition here
ABSCF vs AGYTF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, AGYTF has a market cap of 504.6M. Regarding current trading prices, ABSCF is priced at $1.45, while AGYTF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas AGYTF's P/E ratio is -11.00. In terms of profitability, ABSCF's ROE is +0.33%, compared to AGYTF's ROE of +1.75%. Regarding short-term risk, ABSCF and AGYTF have similar daily volatility (0.00).Check AGYTF's competition here
ABSCF vs KHTRF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, KHTRF has a market cap of 467M. Regarding current trading prices, ABSCF is priced at $1.45, while KHTRF trades at $4.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas KHTRF's P/E ratio is -155.00. In terms of profitability, ABSCF's ROE is +0.33%, compared to KHTRF's ROE of -0.01%. Regarding short-term risk, ABSCF is less volatile compared to KHTRF. This indicates potentially lower risk in terms of short-term price fluctuations for ABSCF.Check KHTRF's competition here
ABSCF vs PEXXF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, PEXXF has a market cap of 463.1M. Regarding current trading prices, ABSCF is priced at $1.45, while PEXXF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas PEXXF's P/E ratio is 9.00. In terms of profitability, ABSCF's ROE is +0.33%, compared to PEXXF's ROE of N/A. Regarding short-term risk, ABSCF and PEXXF have similar daily volatility (0.00).Check PEXXF's competition here
ABSCF vs SWDCF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, SWDCF has a market cap of 443.7M. Regarding current trading prices, ABSCF is priced at $1.45, while SWDCF trades at $2.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas SWDCF's P/E ratio is 69.40. In terms of profitability, ABSCF's ROE is +0.33%, compared to SWDCF's ROE of +0.01%. Regarding short-term risk, ABSCF and SWDCF have similar daily volatility (0.00).Check SWDCF's competition here
ABSCF vs VRNOF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, VRNOF has a market cap of 434.2M. Regarding current trading prices, ABSCF is priced at $1.45, while VRNOF trades at $1.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas VRNOF's P/E ratio is -1.21. In terms of profitability, ABSCF's ROE is +0.33%, compared to VRNOF's ROE of -0.30%. Regarding short-term risk, ABSCF is less volatile compared to VRNOF. This indicates potentially lower risk in terms of short-term price fluctuations for ABSCF.Check VRNOF's competition here
ABSCF vs ELTP Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, ELTP has a market cap of 413.5M. Regarding current trading prices, ABSCF is priced at $1.45, while ELTP trades at $0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas ELTP's P/E ratio is 9.60. In terms of profitability, ABSCF's ROE is +0.33%, compared to ELTP's ROE of +0.71%. Regarding short-term risk, ABSCF is less volatile compared to ELTP. This indicates potentially lower risk in terms of short-term price fluctuations for ABSCF.Check ELTP's competition here
ABSCF vs HUMDF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, HUMDF has a market cap of 407.7M. Regarding current trading prices, ABSCF is priced at $1.45, while HUMDF trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas HUMDF's P/E ratio is 2.58. In terms of profitability, ABSCF's ROE is +0.33%, compared to HUMDF's ROE of +2.33%. Regarding short-term risk, ABSCF and HUMDF have similar daily volatility (0.00).Check HUMDF's competition here
ABSCF vs CRLBF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, CRLBF has a market cap of 313.2M. Regarding current trading prices, ABSCF is priced at $1.45, while CRLBF trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas CRLBF's P/E ratio is -2.42. In terms of profitability, ABSCF's ROE is +0.33%, compared to CRLBF's ROE of -0.33%. Regarding short-term risk, ABSCF is less volatile compared to CRLBF. This indicates potentially lower risk in terms of short-term price fluctuations for ABSCF.Check CRLBF's competition here
ABSCF vs CPHRF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, CPHRF has a market cap of 306.2M. Regarding current trading prices, ABSCF is priced at $1.45, while CPHRF trades at $12.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas CPHRF's P/E ratio is 11.50. In terms of profitability, ABSCF's ROE is +0.33%, compared to CPHRF's ROE of +0.24%. Regarding short-term risk, ABSCF is less volatile compared to CPHRF. This indicates potentially lower risk in terms of short-term price fluctuations for ABSCF.Check CPHRF's competition here
ABSCF vs BHCCF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, BHCCF has a market cap of 225.1M. Regarding current trading prices, ABSCF is priced at $1.45, while BHCCF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas BHCCF's P/E ratio is -4.57. In terms of profitability, ABSCF's ROE is +0.33%, compared to BHCCF's ROE of +0.23%. Regarding short-term risk, ABSCF and BHCCF have similar daily volatility (0.00).Check BHCCF's competition here
ABSCF vs PLNHF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, PLNHF has a market cap of 202M. Regarding current trading prices, ABSCF is priced at $1.45, while PLNHF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas PLNHF's P/E ratio is -3.50. In terms of profitability, ABSCF's ROE is +0.33%, compared to PLNHF's ROE of -0.94%. Regarding short-term risk, ABSCF is less volatile compared to PLNHF. This indicates potentially lower risk in terms of short-term price fluctuations for ABSCF.Check PLNHF's competition here
ABSCF vs PHCUF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, PHCUF has a market cap of 188.1M. Regarding current trading prices, ABSCF is priced at $1.45, while PHCUF trades at $7.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas PHCUF's P/E ratio is -707.00. In terms of profitability, ABSCF's ROE is +0.33%, compared to PHCUF's ROE of -0.00%. Regarding short-term risk, ABSCF and PHCUF have similar daily volatility (0.00).Check PHCUF's competition here
ABSCF vs SHIEF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, SHIEF has a market cap of 150.9M. Regarding current trading prices, ABSCF is priced at $1.45, while SHIEF trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas SHIEF's P/E ratio is -7.06. In terms of profitability, ABSCF's ROE is +0.33%, compared to SHIEF's ROE of +1.40%. Regarding short-term risk, ABSCF and SHIEF have similar daily volatility (0.00).Check SHIEF's competition here
ABSCF vs COPHF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, COPHF has a market cap of 131.7M. Regarding current trading prices, ABSCF is priced at $1.45, while COPHF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas COPHF's P/E ratio is -0.02. In terms of profitability, ABSCF's ROE is +0.33%, compared to COPHF's ROE of -5.75%. Regarding short-term risk, ABSCF is less volatile compared to COPHF. This indicates potentially lower risk in terms of short-term price fluctuations for ABSCF.Check COPHF's competition here
ABSCF vs BIOYF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, BIOYF has a market cap of 129M. Regarding current trading prices, ABSCF is priced at $1.45, while BIOYF trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas BIOYF's P/E ratio is 20.44. In terms of profitability, ABSCF's ROE is +0.33%, compared to BIOYF's ROE of +0.23%. Regarding short-term risk, ABSCF is less volatile compared to BIOYF. This indicates potentially lower risk in terms of short-term price fluctuations for ABSCF.Check BIOYF's competition here
ABSCF vs CBWTF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, CBWTF has a market cap of 127M. Regarding current trading prices, ABSCF is priced at $1.45, while CBWTF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas CBWTF's P/E ratio is 3.14. In terms of profitability, ABSCF's ROE is +0.33%, compared to CBWTF's ROE of +0.29%. Regarding short-term risk, ABSCF is less volatile compared to CBWTF. This indicates potentially lower risk in terms of short-term price fluctuations for ABSCF.Check CBWTF's competition here
ABSCF vs LOVFF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, LOVFF has a market cap of 126.4M. Regarding current trading prices, ABSCF is priced at $1.45, while LOVFF trades at $1.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas LOVFF's P/E ratio is 14.67. In terms of profitability, ABSCF's ROE is +0.33%, compared to LOVFF's ROE of +0.12%. Regarding short-term risk, ABSCF and LOVFF have similar daily volatility (0.00).Check LOVFF's competition here
ABSCF vs NWPN Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, NWPN has a market cap of 123.7M. Regarding current trading prices, ABSCF is priced at $1.45, while NWPN trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas NWPN's P/E ratio is -0.04. In terms of profitability, ABSCF's ROE is +0.33%, compared to NWPN's ROE of +0.13%. Regarding short-term risk, ABSCF is less volatile compared to NWPN. This indicates potentially lower risk in terms of short-term price fluctuations for ABSCF.Check NWPN's competition here
ABSCF vs CWBHF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, CWBHF has a market cap of 121.5M. Regarding current trading prices, ABSCF is priced at $1.45, while CWBHF trades at $0.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas CWBHF's P/E ratio is -5.44. In terms of profitability, ABSCF's ROE is +0.33%, compared to CWBHF's ROE of -1.20%. Regarding short-term risk, ABSCF is less volatile compared to CWBHF. This indicates potentially lower risk in terms of short-term price fluctuations for ABSCF.Check CWBHF's competition here
ABSCF vs LPCUF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, LPCUF has a market cap of 112.1M. Regarding current trading prices, ABSCF is priced at $1.45, while LPCUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas LPCUF's P/E ratio is 9.51. In terms of profitability, ABSCF's ROE is +0.33%, compared to LPCUF's ROE of +0.04%. Regarding short-term risk, ABSCF and LPCUF have similar daily volatility (0.00).Check LPCUF's competition here
ABSCF vs CNVCF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, CNVCF has a market cap of 109.2M. Regarding current trading prices, ABSCF is priced at $1.45, while CNVCF trades at $6.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas CNVCF's P/E ratio is -5.00. In terms of profitability, ABSCF's ROE is +0.33%, compared to CNVCF's ROE of +1.21%. Regarding short-term risk, ABSCF and CNVCF have similar daily volatility (0.00).Check CNVCF's competition here
ABSCF vs HLTRF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, HLTRF has a market cap of 105.1M. Regarding current trading prices, ABSCF is priced at $1.45, while HLTRF trades at $3.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas HLTRF's P/E ratio is -8.62. In terms of profitability, ABSCF's ROE is +0.33%, compared to HLTRF's ROE of -0.19%. Regarding short-term risk, ABSCF and HLTRF have similar daily volatility (0.00).Check HLTRF's competition here
ABSCF vs ORXOY Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, ORXOY has a market cap of 97.2M. Regarding current trading prices, ABSCF is priced at $1.45, while ORXOY trades at $2.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas ORXOY's P/E ratio is -2.24. In terms of profitability, ABSCF's ROE is +0.33%, compared to ORXOY's ROE of +5.65%. Regarding short-term risk, ABSCF and ORXOY have similar daily volatility (0.00).Check ORXOY's competition here
ABSCF vs AAWH Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, AAWH has a market cap of 96.5M. Regarding current trading prices, ABSCF is priced at $1.45, while AAWH trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas AAWH's P/E ratio is -0.82. In terms of profitability, ABSCF's ROE is +0.33%, compared to AAWH's ROE of -14.10%. Regarding short-term risk, ABSCF is less volatile compared to AAWH. This indicates potentially lower risk in terms of short-term price fluctuations for ABSCF.Check AAWH's competition here
ABSCF vs JUSHF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, JUSHF has a market cap of 92.1M. Regarding current trading prices, ABSCF is priced at $1.45, while JUSHF trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas JUSHF's P/E ratio is -1.42. In terms of profitability, ABSCF's ROE is +0.33%, compared to JUSHF's ROE of +0.89%. Regarding short-term risk, ABSCF is less volatile compared to JUSHF. This indicates potentially lower risk in terms of short-term price fluctuations for ABSCF.Check JUSHF's competition here
ABSCF vs ORXOF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, ORXOF has a market cap of 79.3M. Regarding current trading prices, ABSCF is priced at $1.45, while ORXOF trades at $2.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas ORXOF's P/E ratio is -1.83. In terms of profitability, ABSCF's ROE is +0.33%, compared to ORXOF's ROE of +5.65%. Regarding short-term risk, ABSCF and ORXOF have similar daily volatility (0.00).Check ORXOF's competition here
ABSCF vs GRUSF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, GRUSF has a market cap of 74.9M. Regarding current trading prices, ABSCF is priced at $1.45, while GRUSF trades at $0.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas GRUSF's P/E ratio is 10.00. In terms of profitability, ABSCF's ROE is +0.33%, compared to GRUSF's ROE of +0.28%. Regarding short-term risk, ABSCF is less volatile compared to GRUSF. This indicates potentially lower risk in terms of short-term price fluctuations for ABSCF.Check GRUSF's competition here
ABSCF vs MEDXF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, MEDXF has a market cap of 73.7M. Regarding current trading prices, ABSCF is priced at $1.45, while MEDXF trades at $2.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas MEDXF's P/E ratio is -114.10. In terms of profitability, ABSCF's ROE is +0.33%, compared to MEDXF's ROE of -0.01%. Regarding short-term risk, ABSCF is less volatile compared to MEDXF. This indicates potentially lower risk in terms of short-term price fluctuations for ABSCF.Check MEDXF's competition here
ABSCF vs EOFBY Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, EOFBY has a market cap of 73.7M. Regarding current trading prices, ABSCF is priced at $1.45, while EOFBY trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas EOFBY's P/E ratio is -7.67. In terms of profitability, ABSCF's ROE is +0.33%, compared to EOFBY's ROE of -0.77%. Regarding short-term risk, ABSCF and EOFBY have similar daily volatility (0.00).Check EOFBY's competition here
ABSCF vs GDNSF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, GDNSF has a market cap of 61M. Regarding current trading prices, ABSCF is priced at $1.45, while GDNSF trades at $0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas GDNSF's P/E ratio is -2.66. In terms of profitability, ABSCF's ROE is +0.33%, compared to GDNSF's ROE of -0.69%. Regarding short-term risk, ABSCF and GDNSF have similar daily volatility (0.00).Check GDNSF's competition here
ABSCF vs DBCCF Comparison March 2026
ABSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABSCF stands at 96M. In comparison, DBCCF has a market cap of 53.4M. Regarding current trading prices, ABSCF is priced at $1.45, while DBCCF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABSCF currently has a P/E ratio of -8.53, whereas DBCCF's P/E ratio is 4.63. In terms of profitability, ABSCF's ROE is +0.33%, compared to DBCCF's ROE of +0.13%. Regarding short-term risk, ABSCF and DBCCF have similar daily volatility (0.00).Check DBCCF's competition here